Skip to main content
MDGL logo

Madrigal Pharmaceuticals, Inc.

MDGLNASDAQHealthcareBiotechnology

$434.24Today:- (-)1Y +6.95%

As of Oct 23, 2026 close

Market cap
$12.66B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$393.61$615.00
Volume (live)
-
Avg. volume (3M)
278.81K

Madrigal Pharmaceuticals, Inc. (MDGL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Madrigal Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(17 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$683.67
+57.44% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MDGL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jason Zemansky
BofA Securities
HoldReiterates
$543.00 → $533.00
Sadia Rahman
Wells Fargo
BuyMaintains
$685.00
Ashwani Verma
UBS
BuyMaintains
$669.00 → $735.00
Sadia Rahman
Wells Fargo
BuyMaintains
$685.00
Andrew Fein
HC Wainwright
BuyReiterates
$620.00
Eliana Merle
Barclays
BuyMaintains
$962.00
Andrea Newkirk
Goldman Sachs
BuyInitiates
$704.00
Eric Joseph
Citi
BuyInitiates
$725.00
Edward Nash
Canaccord Genuity
BuyReiterates
$612.00
Edward Nash
Canaccord Genuity
BuyReiterates
$612.00
Andy Chen
Wolfe Research
BuyUpgrades
$605.00
Edmund Ingham
Forbes
HoldInitiates Coverage
-
Andrew Fein
HC Wainwright
BuyReiterates
$620.00
Srikripa Devarakonda
Truist
BuyReiterates
$709.00
Unknown Analyst
B Riley
BuyInitiates
$670.00
Ritu Baral
TD Cowen
BuyMaintains
$644.00
Jason Zemansky
BofA Securities
HoldReiterates
$553.00 → $543.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 19, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for MDGL?

The analyst consensus rating for MDGL is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for MDGL?

The average 12-month price target for MDGL is $683.67, representing an upside of 57.4% from the Oct 23, 2026 close of $434.24.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.